Edwards Lifesciences (NYSE:EW) traded lower in the premarket on Thursday after Wolfe Research downgraded the heart device ...

The 1,000th TAVR, combined with a commitment to safety and quality outcomes, solidifies Doylestown as an elite structural ...

Doylestown Health’s Heart and Vascular Services team recently performed its 1,000th transcatheter aortic valve replacement at ...

Risk for bleeding events is significantly affected by DOAC score in patients with atrial fibrillation who have received TAVR.

The following is a summary of “Computed tomography derived predictors of left ventricular obstruction after TAVR,” published ...

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, TAVR, diabetes tech ...

THE SOLVE-TAVI trial demonstrated that both valve type and anaesthesia strategy yielded comparable long-term outcomes in ...

An innovative heart procedure is changing the lives of patients with aortic valve disease. It's called transcatheter aortic ...

Anteris Technologies' DurAVR system expected to capture 4%-5% of the U.S. TAVR market by 2030, driven by strong clinician preference for BEV Analyst forecasts DurAVR's superior hemodynamics ...

Lipoprotein(a) doesn’t influence calcification or outcomes in TAVR, shifting focus to other AS progression factors.

North America to Lead Revenue While Asia Pacific Emerges as the Fastest-Growing Region, Driven by Rising Cardiovascular Cases ...